140 likes | 255 Views
Health Net, Inc. David W. Olson Senior Vice President -- Investor Relations February 28, 2001. Lehman Brothers Global Healthcare Conference. Cautionary Statement.
E N D
Health Net, Inc. David W. Olson Senior Vice President -- Investor Relations February 28, 2001 Lehman Brothers Global Healthcare Conference
Cautionary Statement The matters discussed in this release contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, that involve risks and uncertainties. All statements other than statements of historical information provided herein may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects” and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those reflected in the forward-looking statements include, but are not limited to, the risks discussed in the “Risk Factors” and “Cautionary Statements” sections included within the Company's most recent Annual Report on Form 10-K filed with the SEC and the risks discussed in the Company's other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis, judgment, belief or expectation only as of the date hereof. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
Overview • From Turnaround to Growth • 2000 Review • The Growth Story • Long-Term -- Issues and Targets
From Turnaround to Growth • Rationalized and Focused Businesses • Divested Non-Core Businesses • Priced Products Appropriately • Improved Our Balance Sheet • Debt Down Substantially on TRICARE Settlement and Cash • Met Earnings Expectations Over the Last Eight Quarters • Dramatically Improved Cash Flow, and • Prepared for Solid Earnings Growth in ‘01
Finishing the Turnaround • Close Florida Transaction • Confirm Arizona Corrective Actions • Significant Re-pricing and Health Care Cost Containment Initiatives
Q4 and ‘00 Performance Highlights • $.37 EPS in Q4 Met Expectations • Cash Flow of $366 Million for 2000 Above Target • Debt Now Below $600 Million • Was $766 Million at Year-End • Was $1.4 Billion at End of Q3 ‘98 • Debt-to-Capital to 39 Percent Pro Forma • Claims Payable Up $73 Million Sequentially • Stockholders’ Equity $1.1 Billion
The Growth Story • California and the Northeast • Profitable Enrollment Gains -- Outstanding Q4 • New Products • Niche Markets • Sustain Government and Specialty Businesses • Focus on SG&A and Technology • Position for Consistent Annual EPS Growth of 15% to 20%
California and the Northeast • Strong Positions in Largest Markets • California -- Solid Market Reputation • Known for Large Group • California Group Model Stabilizing • Slow Shift to Shared Risk Continues • Tri-State -- PHS Open Access Aligned with Market Needs • Largest FFS Tri-State Network
Profitable Enrollment Gains • Favorable Pricing Outlook • Solid Provider Relationships • California Small Group Opportunity • Nine New PPO Products in California • Groundbreaking Latino Product • New York Competitive Climate • PHS Growth Coming in New York • Joint Venture in Small Group
Sustain Government/Specialty • TRICARE Settlement Clears Decks • Contract Extensions Secured • Economics Improved • Limited Receivable Build • Specialty Businesses Doing Well • MHN Still an Opportunity
SG&A and Technology • Importance of Customer Service in More Open Product Environment • Questium • Use Technology to Significantly Improve Processes/Cut Costs for All • Provider Connectivity • Enrollment/Billing • Infrastructure
General Long-Term Targets • Double-Digit Health Plan Revenue Growth • Pricing and Enrollment Growth • Flat to Lower Health Plan MCR • SG&A Down by at Least 100 Bps over 3-Year Period • Debt-to-Total Capital Below 30 Percent by 2003 • Consistent ROE of 20% by 2003
Issues • Patients’ Bill of Rights • Class Action Litigation • Medicare
Conclusions • Strong Positions in the Two Largest Markets • Sustainable Provider Relationships • Open Access Product Expertise • Open, Experienced, Change-Oriented Management Team • Willingness to Exploit Technology to Change Processes and Structures